Keyphrases
Interleukin-6
100%
Progression Rate
100%
Age-related Macular Degeneration
100%
Geographic Atrophy
100%
Chronic Inflammation
33%
Healthy Controls
25%
Enlargement
25%
Neovascular Age-related Macular Degeneration (nAMD)
25%
Clinical Phenotype
16%
C-reactive Protein
16%
TNF Receptor 2 (TNFR2)
16%
Interleukin-8
16%
Inflammation
16%
Current Treatment
8%
Disease Activity
8%
Inflammatory Markers
8%
Disease Biomarker
8%
Autofluorescence
8%
Plasma Parameters
8%
Interleukin-1β
8%
Fundus Autofluorescence
8%
Plasma Biomarkers
8%
Predictive Ability
8%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 6
100%
Geographic Atrophy
100%
Age Related Macular Degeneration
100%
Chronic Inflammation
33%
Wet Macular Degeneration
25%
C Reactive Protein
16%
Interleukin 8
16%
Inflammation
16%
Tumor Necrosis Factor Receptor 2
16%
Disease Activity
8%
Biological Marker
8%
Cytokine
8%
Neuroscience
Age-Related Macular Degeneration
100%
Interleukin 6
100%
Blood Plasma
57%
Interleukin 8
28%
C-Reactive Protein
28%
Tumor Necrosis Factor Receptor 2
28%
Autofluorescence
14%
Interleukin
14%
Biochemistry, Genetics and Molecular Biology
Interleukin 6
100%
Blood Plasma
60%
Tumor Necrosis Factor Receptor
40%
C-Reactive Protein
40%
Interleukin 8
40%
Autofluorescence
20%
Cytokine
20%
Blood Level
20%
Immunology and Microbiology
Interleukin 6
100%
Blood Plasma
60%
C-Reactive Protein
40%
Interleukin 8
40%
Tumor Necrosis Factor Receptor 2
40%
Cytokine
20%
Blood Level
20%
Autofluorescence
20%